Re: Strand N et al. Evidence-Based Clinical Guidelines from the American Society of Pain and Neuroscience for the Use of Implantable Peripheral Nerve Stimulation in the Treatment of Chronic Pain. J Pain Res. 2022 Aug 23;15:2483–2504 [Letter]

Robert Heros1 Spinal Diagnostics, Tualatin, OR, USACorrespondence[email protected]

Christopher J Gilligan2 Division of Pain Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Krishnan V Chakravarthy3 Coastal Pain and Spinal Diagnostics, San Diego, CA, USA

References

Strand N, D’Souza RS, Hagedorn JM, et al. Evidence-based clinical guidelines from the American Society of Pain and Neuroscience for the use of implantable peripheral nerve stimulation in the treatment of chronic pain. J Pain Res. 2022;15:2483–2504. doi:10.2147/JPR.S362204
PubMed Web of Science ®Google Scholar
Deer TR, Gilmore CA, Desai MJ, et al. Percutaneous peripheral nerve stimulation of the medial branch nerves for the treatment of chronic axial back pain in patients after radiofrequency ablation. Pain Med. 2021;22(3):548–560. doi:10.1093/pm/pnaa432
PubMed Web of Science ®Google Scholar
Gilmore CA, Kapural L, McGee MJ, et al. Percutaneous peripheral nerve stimulation for chronic low back pain: prospective case series with 1 year of sustained relief following short-term implant. Pain Pract. 2020;20(3):310–320. doi:10.1111/papr.12856
PubMed Web of Science ®Google Scholar
Gilligan C, Volschenk W, Russo M, et al. An implantable restorative-neurostimulator for refractory mechanical chronic low back pain: a randomized sham-controlled clinical trial. Pain. 2021;162(10):2486–2498. doi:10.1097/j.pain.0000000000002258
PubMed Web of Science ®Google Scholar
Gilligan C, Volschenk W, Russo M, et al. Three-year durability of restorative neurostimulation effectiveness in patients with chronic low back pain and multifidus muscle dysfunction. Neuromodulation Technol Neural Interface. 2022. doi:10.1016/j.neurom.2022.08.457
Google Scholar